Suppression in Biological Technology
Navigation Links
Suppression in Biological Technology
Allied Minds Establishes New Company to Commercialize Novel UC Irvine Tinnitus Therapy
... LLC to commercialize a novel acoustic therapy for the treatment and suppression of tinnitus originally developed at UC Irvine. Tinnitus is a ... the effects of tinnitus. The technology has shown to provide long-term suppression of tinnitus through treatment. "We are very excited about the ...Tolera Therapeutics Granted Orphan Drug Designation for Organ Transplant Rejection Drug
... to market given the patient's need for safer and more effective immune suppression therapy. Doctors are in need of alternatives to traditional immune suppression approaches, and the current industry pipeline offers few solutions to ...Nycomed's Ciclesonide to be Commercialised in the United States by Sepracor
... inhaled corticosteroids may lead to signs or symptoms of hypercorticism, suppression of hypothalamic-pituitary-adrenal (HPA) function and/or suppression of growth in children. Glaucoma, increased intraocular pressure and ...ALVESCO(R) Gains FDA Approval for the U.S. Market
... inhaled corticosteroids may lead to signs or symptoms of hypercorticism, suppression of hypothalamic-pituitary-adrenal (HPA) function and/or suppression of growth in children. Glaucoma, increased intraocular pressure and ...Study Reaffirms Superiority of Trofile(TM) Assay
... infected with D/M or X4-tropic HIV, it may not contribute to virologic suppression and could result in emergence of resistance to other drugs in the ... infected with D/M or X4-tropic HIV, it may not contribute to virologic suppression and could result in emergence of resistance to other drugs in the ...Orexigen(R) Therapeutics to Speak at Canaccord Adams Global Growth Conference
... Each product candidate is designed to act on a specific group of neurons in the central nervous system with the goal of achieving appetite suppression and sustained weight loss. Further information about the Company can be found at www.orexigen.com . ...... to debilitating consequences, e.g., joint contractures, loss of sight, end-stage lung disease, or mortality resulting from profound chronic immune suppression leading to recurrent or life-threatening infections. Treatment of cGVHD is a challenge because it can be refractory to frontline ...
... ) VEGF plays a critical role in the formation of new blood vessels or angiogenesis and its suppression has been shown to decrease tumor size and improve hearing in some patients with NF2. PTC299 selectively blocks the tumor-related production of VEGF, ...
Orexigen(R) Therapeutics Announces Full Exercise of Overallotment Option by Underwriters
... of 2009. Each product candidate is designed to act on a specific group of neurons in the central nervous system with the goal of achieving appetite suppression and sustained weight loss, through combination therapeutic approaches. Further information about the Company can be found at ....... rate of recurrences. In fact, 40% to 80% of patients experience a recurrence within only a year after undergoing short-term treatment of gastric acid suppression therapy. Studies have shown that the gastroduodenal reoccurrence rate is only 2% for patients in whom the organism has been eradicated. ...
... Each product candidate is designed to act on a specific group of neurons in the central nervous system with the goal of achieving appetite suppression and sustained weight loss. Further information about the Company can be found at http://www.orexigen.com . Forward-Looking Statements ...
... Each product candidate is designed to act on a specific group of neurons in the central nervous system with the goal of achieving appetite suppression and sustained weight loss. Further information about the Company can be found at http://www.orexigen.com . ...
Orexigen(R) Therapeutics to Present at Upcoming Meetings
... Each product candidate is designed to act on a specific group of neurons in the central nervous system with the goal of achieving appetite suppression and sustained weight loss. Further information about the Company can be found at http://www.orexigen.com . ...... Each product candidate is designed to act on a specific group of neurons in the central nervous system with the goal of achieving appetite suppression and sustained weight loss. Further information about the Company can be found at http://www.orexigen.com . Forward-Looking Statements ...
Orexigen(R) Therapeutics to Speak at Upcoming Conferences
... Each product candidate is designed to act on a specific group of neurons in the central nervous system with the goal of achieving appetite suppression and sustained weight loss. Further information about the company can be found at http://www.orexigen.com . ...Orexigen(R) Therapeutics Announces First Quarter 2009 Financial Results
... time. Each product candidate is designed to act on a specific group of neurons in the central nervous system with the goal of achieving appetite suppression and sustained weight loss. Further information about the Company can be found at www.orexigen.com . Forward-Looking Statements ...First Patient Dosed in Phase I Clinical Trial of Tigris Pharmaceuticals' GGTI-2418
... of the tumor suppressor Rb. GGTase I inhibitors also induce apoptosis by a mechanism involving downregulation of the expression of survivin and suppression of the activation of PI3K/Akt. About Tigris Pharmaceuticals, Inc. Tigris Pharmaceuticals, Inc. is a privately held biopharmaceutical company ...Pharmalink AB Completes Phase II Clinical Study With Renal Disease Drug Nefecon(R)
... disease. Nefecon is an enteric formulation of a locally acting corticosteroid which downregulates the inflammatory process in the kidneys through suppression of the gut immune system. Sixteen patients at trial centers in Sweden were treated for six months followed by a three month follow up period. ...... Each product candidate is designed to act on a specific group of neurons in the central nervous system with the goal of achieving appetite suppression and sustained weight loss. Further information about the Company can be found at http://www.orexigen.com . Forward-Looking Statements ...
... from multiple genotypes (1a, 1b, 2a and 4a) and in HCV replicons. Long-term in vitro treatment (14 days) with IDX316 produced high levels of suppression that was maintained over the treatment period without evidence of rebound or cytotoxicity. IDX316 also demonstrated high selectivity, with tight ...
... over time. Each product candidate is designed to act on a specific group of neurons in the central nervous system with the goal of achieving appetite suppression and sustained weight loss. Further information about the Company can be found at www.orexigen.com . ...
FDA Accepts Investigational New Drug (IND) Application for Tigris Pharmaceutical's GGTI-2418
... of the tumor suppressor Rb. GGTase I inhibitors also induce apoptosis by a mechanism involving downregulation of the expression of survivin and suppression of the activation of PI3K/Akt. About Tigris Pharmaceuticals, Inc. Tigris Pharmaceuticals, Inc. is a privately held biopharmaceutical ...... presented demonstrate that IQP-0410 is well tolerated and safe with plasma drug concentrations 10-20-fold greater than those required for complete suppression of HIV replication at 24-hours following oral administration. Thus, IQP-0410 can be dosed once per day, and possesses a highly positive safety ...
Tigris Pharmaceuticals Files IND Application for GGTI-2418
... of the tumor suppressor Rb. GGTase I inhibitors also induce apoptosis by a mechanism involving downregulation of the expression of survivin and suppression of the activation of PI3K/Akt. About Tigris Pharmaceuticals, Inc. Tigris Pharmaceuticals, Inc. is a privately held biopharmaceutical company ...Orexigen(R) Therapeutics to Speak at BIO CEO & Investor Conference
... Each product candidate is designed to act on a specific group of neurons in the central nervous system with the goal of achieving appetite suppression and sustained weight loss. Further information about the company can be found at http://www.orexigen.com . ...Plasmonic whispering gallery microcavity paves the way to future nanolasers
... for SPP modes at room temperature. "This nearly ideal value, which is close to the theoretical metal-loss-limited Q factor, is attributed to the suppression and minimization of radiation and scattering losses that are made possible by the geometrical structure and the fabrication method," said Min, who ...Anthera Completes Enrollment and Dosing of Varespladib Cardiovascular Trial
... of secretory phospholipase A2 (sPLA2), has demonstrated marked improvements in independent markers of cardiovascular risk including a near complete suppression of the target enzyme sPLA2, a clinically meaningful and statistically significant reduction in "bad" LDL cholesterol, and a reduction in C-reactive ...... product candidate is designed to act on a specific group of neurons in the central nervous system with the goal of achieving appetite suppression and sustained weight loss. Further information about the company can be found at http://www.orexigen.com . Forward-Looking Statements ...
Orexigen(R) Therapeutics Issued a Key Fourth U.S. Patent on Contrave(R)
... product candidate is designed to act on a specific group of neurons in the central nervous system with the goal of achieving appetite suppression and sustained weight loss. Further information about the company can be found at http://www.Orexigen.com . Forward-Looking Statements ...Indevus Pharmaceuticals Announces Fiscal 2008 Year End and Fourth Quarter Results
... Normal Testosterone Levels Throughout Treatment -- Results From Two-Year Study Confirming SUPPRELIN LA Implant Maintains Profound suppression of Hormones in Children with Premature Onset Puberty -- Completion of Enrollment in Phase III Trial of PRO 2000 -- Phase III Clinical ...SuperGen Receives Clearance to Begin Clinical Trials With SGI-1776, a PIM Inhibitor
... a first-in-class agent." Treatment with SGI-1776 produces significant tumor regressions in animal models of acute myeloid leukemia and suppression of solid tumor growth and biomarker modulation in models of prostate adenocarcinoma and non-Hodgkin's lymphoma. In non-clinical studies, SGI-1776 has ...Comedy 'Horror In The Wind' Banned In New Mexico
... and James Dobson win the White House with a campaign theme of the "War on Sex." Religious fanatic Robertson steals an untested sex suppression formula and spreads it throughout the world. To everyone's shock, the untested Formula 4708 does not suppress sex drive but changes it. Within a ...Orexigen(R) Therapeutics Announces Third Quarter 2008 Financial Results
... Each product candidate is designed to act on a specific group of neurons in the central nervous system with the goal of achieving appetite suppression and sustained weight loss. Beyond obesity, Orexigen is developing drug combinations for use in schizophrenia and obsessive-compulsive ...... non-Hodgkin's lymphoma patients." High-dose Zevalin was well tolerated and no deaths were noted with this regimen. The expected severe marrow suppression associated with myeloablative treatment was seen but patients began to recover neutrophil and platelet counts within 3 weeks. Only minor ...
... Each product candidate is designed to act on a specific group of neurons in the central nervous system with the goal of achieving appetite suppression and sustained weight loss. Beyond obesity, Orexigen is developing drug combinations for use in schizophrenia and obsessive-compulsive ...
... Each product candidate is designed to act on a specific group of neurons in the central nervous system with the goal of achieving appetite suppression and sustained weight loss. Beyond obesity, Orexigen is developing drug combinations for use in schizophrenia and obsessive-compulsive disorder. ...
... Each product candidate is designed to act on a specific group of neurons in the central nervous system with the goal of achieving appetite suppression and sustained weight loss. Beyond obesity, Orexigen is developing drug combinations for use in schizophrenia and obsessive-compulsive disorder. ...
GM crops protect neighbors from pests
... and rainfall along with the introduction of the genetically modified cotton, and confirmed that Bt cotton was responsible for the long-term suppression of the pests in the cotton and a host of other un-modified crops after 10 years. Dr. Wu and colleagues suggest that this may be because cotton is the ...Orexigen(R) Therapeutics to Present at Upcoming Investor Conferences
... over time. Each product candidate is designed to act on a specific group of neurons in the central nervous system with the goal of achieving appetite suppression and sustained weight loss. Further information about the Company can be found at http://www.orexigen.com . ...Halozyme Therapeutics Reports 2008 Second Quarter Financial Results
... own natural insulin. This could lead to the development of a best-in-class product. We have also demonstrated in animal models significant tumor suppression for PEGPH20 plus chemotherapy and controlled degradation of a structural component of the skin with HTI-501 that may prove beneficial in various ...Other ContentshydrochlorichydrochlorichydronephrosishydatidfetalishydrocelehydatidiformOther TagsGlobulinGlobulinisoisoisoisoisoisoisoisoIECIECIECalbumalbumPeelOther Tagsroutine 2routine 3routine 4routine 5skill 2
(Date:11/26/2009)...essive antlers, red deer have been caught in the h...rs are much more than decorative. They are lethal ...ohn Currey, from The University of York, UK, has b... for over half a century and has become fascinated...long-standing collaboration with Tomas Landete-Cas...
(Date:11/26/2009)...istant Staphylococcus Aureus ) and other drug-res...perature plasma prototype devices have been develo...ricidal cocktails. , Two prototype devices have ...healthy skin (e.g. hands and feet) in hospitals an...hreat; and another to shoot bacteria-killing agent...
(Date:11/25/2009)...Head of the Cell Death Research Laboratory in the ...een awarded the prestigious Johnson & Johnson Focu...ause of brain cell damage in Parkinson,s disease. ...s in support of innovation and excellence in scien...d earlier this month at an event at the Hyatt Rege...
Breaking Biology News(10 mins):Tough yet stiff deer antler is materials scientist's dream 2Plasma produces KO cocktail for MRSA 2Plasma produces KO cocktail for MRSA 3Johnson & Johnson award goes to research of the cause of brain cell damage in Parkinson's 2A New Jersey Anti Poverty Charity Meets a Crisis of Need with Charitable Giving from Local Paterson NJ Small Businesses 58591 1A New Jersey Anti Poverty Charity Meets a Crisis of Need with Charitable Giving from Local Paterson NJ Small Businesses 58591 2A New Jersey Anti Poverty Charity Meets a Crisis of Need with Charitable Giving from Local Paterson NJ Small Businesses 58591 3A New Jersey Anti Poverty Charity Meets a Crisis of Need with Charitable Giving from Local Paterson NJ Small Businesses 58591 4Doctor Visits Are Getting Short Shrift in Tight Economy 58589 1Doctor Visits Are Getting Short Shrift in Tight Economy 58589 2Study Urges Treatment for Even Mild Gestational Diabetes 58587 1Study Urges Treatment for Even Mild Gestational Diabetes 58587 2Study Urges Treatment for Even Mild Gestational Diabetes 58587 3(Date:11/26/2009)... Dr. David Kim of the Live Life Again Ce...Dallas , is one of a growing number of physicians ...king sites to connect with individuals who are int... morbid obesity. Dr. Kim is utilizing Facebook to ...t his practice with the community. , ...
(Date:11/25/2009)...inn.,Nov.25/PRNewswire-USNewswire/--Whenmostpeople...opractorcanalsogivepatientsthehelptheyneed.TMJstan...aw(mandible)contacts/connectswithyourskull(tempora...MJdysfunctionarepainwithchewing,clickingorpoppingo...unctionincluding:headaches,fatigue,sleepdisturbanc...
(Date:11/25/2009)...,Nov.25/PRNewswire/-SentinelleMedicalInc.,aleading...onsoftwarelaunchesasuiteofnewleadingedgeclinicalap...formatthisyear,sRadiologicalSocietyofNorthAmerica(...h5800,HallA).Theapplicationsleveragetheuniquehighq...magingcoilsandsupportmultipleimagingmodalitiesform...
(Date:11/25/2009)...CISCO,Nov.25/PRNewswire/--TheBayAreaAirQualityMana...Spare the Air Alert forThursday,Novembe...ranyothersolidfuel,bothindoorsandoutdoors. ,, "...tytomorrow,"saidJackBroadbent,executiveofficerofth...thehealthoftheirneighborsandfellowcommunitymembers...
(Date:11/25/2009)...s discovery that grew out of a collaboration betwe... offer hope to the nearly 10 million Americans who...Also known as hardening of the arteries, periphera...y problem in which narrowed arteries reduce blood ...ed flag for vascular disease, heart attack and str...
Breaking Medicine News(10 mins):Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 2Health News:Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients 3Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 2Health News:Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology 3Health News:Winter Spare the Air Alert in Effect for Thursday, November 26, 2009 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4[1] Dallas Texas Weight Loss Surgeon Using Social Media To Reach Out to Patients[1] TMJ and Chiropractic Care: An Overall Wellness Approach[1] Sentinelle Medical Launches Aegis Suite of Oncology 4D Visualization Software with PureWeb(TM) Technology[0] Winter Spare the Air Alert in Effect for Thursday, November 26, 2009[1] Engineers, doctors at UCLA develop novel material that could help fight arterial disease
| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |